Vimarsana
Biggest News Aggregation in the World

Page 5 - Applied Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Applied Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Applied Testing Today - Breaking & Trending Today

QIAGEN N.V.: QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases - Vimarsana News

QIAGEN N.V.: QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases

Partnership to leverage the Helix Laboratory Platform powered by QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise Addressing health burden in neuro-degenerative

QIAGEN N.V.: QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics' KRAZATI in non-small cell lung cancer - Vimarsana News

QIAGEN N.V.: QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics' KRAZATI in non-small cell lung cancer

therascreenKRAS RGQ PCR kit approved as a companion diagnostic to aid in identifying non-small cell lung cancer (NSCLC) patients eligible for treatment with KRAZATI (adagrasib) KRAS mutations

QIAGEN N.V.: QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance - Vimarsana News

QIAGEN N.V.: QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance

NeuMoDx MPXV Test Strip enables researchers to quickly identify both clade I II of the monkeypox virus Dual-target design to reduce false negatives Multiplex test strengthens QIAGEN's

QIAGEN N.V.: QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug - Vimarsana News

QIAGEN N.V.: QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug

Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN's NGS testing

QIAGEN N.V.: U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases - Vimarsana News

QIAGEN N.V.: U.S. CDC Endorses the Use of Digital PCR Technology for Wastewater Surveillance of Infectious Diseases

U.S. public health agency validated digital PCR technologies including QIAcuity as the way to reliably detect multiple disease targets in wastewater samples QIAcuity previously awarded U.S.